Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

White Paper: New horizons to drive the future of Medicine

07.06.2013
The European Technology Platform on Nanomedicine (ETPN) and the NANOMED2020 project announce the publication of the White Paper on Contribution of Nanomedicine to Horizon 2020, the next European Framework Programme for Research and Innovation till 2020.

This strategic document provides a set of key recommendations for the European Commission and the EU Member States to create a favourable ecosystem for the successful deployment of Nanomedicine in Europe. It lays thereby the groundwork to manage the efficient translation of nanotechnology from a Key Enabling Technology (KET) into new and innovative medical products.

Nanomedicine, also defined as the use of nanotechnologies in medicine, supports a strong research and emerging industrial healthcare sector in Europe. Based on excellent academic research and innovative SMEs, nanomedicine has the potential to answer today’s societal challenges such as the ageing population. ETPN’s White Paper will actively contribute to shaping the three pillars of “Horizon 2020 – Excellence in Science, Industrial Leadership and Societal Challenges”.

Based on an in-depth analysis of the main bottlenecks in the translation of nanomedicine to the market, i.e. the inefficient selection process of translatable projects and the lack of technical infrastructures, such as pharmacology and toxicology facilities, the White Paper strives for the creation of an strong SME based supply chain for innovative therapeutics and diagnostics as a profitable industrial sector. This will support innovation, competitiveness and keep production and high tech jobs in Europe for the benefit of both the European economy and European patients.

The pivotal proposition of the White Paper is the establishment of a Nanomedicine Translation Hub designed as an umbrella for a set of complementary actions and initiatives such as:

• a dedicated Nanomedicine Translation Advisory Board (TAB) with experienced industrial experts to select, guide and push forward the best translatable concepts,
• an European Nano-Characterisation Laboratory (EU-NCL) for physical, chemical and biological characterisation of nanomaterials intended for medical use,
• GMP manufacturing pilot lines for clinical batches to assist both academia and SMEs to develop nanomedical materials for validation in clinical trials, before transfer to dedicated manufacturing organisations,

• a dedicated NanoMed SME instrument aiming at funding discovery projects and innovative SMEs in order to keep excellence in nanomedicine research and more importantly develop products.

Nano-concepts for a macro-impact on EU economy

The implementation of these recommendations in Horizon 2020 represents a unique opportunity for Europe to foster innovation in healthcare and to push for the emergence of a leading nanomedicine sector. With an estimated total budget of 800 Mio €, it will therefore actively contribute to the re-localisation of pharmaceutical research and to the re-industrialisation of Europe, being thereby a significant factor for growth and for job creation. With nearly 250 “nano”-products used or tested in humans worldwide, representing about 10% of pharma sales and a $130.9 billion market by 2016, nanomedicine is meant to have a real impact on the European economy.

The European Commission has the potential to play a major role in this process through its framework programme Horizon 2020. In coordination with Member States and by funding the research of cutting-edge technologies for the future of Medicine, by de-risking innovation in SMEs and by facilitating the dialogue with regulatory authorities and large industrial partners, the European Commission can actively support the nanomedical sector for the benefit of the patients.

The White Paper “Contribution of Nanomedicine to Horizon 2020” is available for download on the ETP Nanomedicine website under http://www.etp-nanomedicine.eu/etpn-white-paper-2013

About the ETP Nanomedicine

The ETP Nanomedicine has been established in 2005 as a joint venture of the European Commission and CEOs of large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. With more than 120 active members from industry, academia, healthcare providers and public authorities, the ETPN coordinates joint research efforts together with its members, the European Commission and the EU Member States. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe and contributed to set up numerous EU funded projects providing thus a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicines.

About NANOMED2020

NANOMED2020 is a Coordination and Support Action under the FP7-Health aiming at delivering concrete recommendations to the European Commission to push forward the field of nanomedicine under Horizon 2020. Amongst other activities, NANOMED2020 is focusing on

• federating the nanomedicine community and establishing a European landscape via mapping all relevant actors, projects and infrastructures and

• identifying the key bottlenecks of the value chain to focus on to leverage the translational possibilities of the development process and to bring in the end more products onto the market.

This project involves seven partners across Europe including the ETPN Secretariat, the CLINAM foundation (Switzerland), the National Institute of Health Carlos III (Spain), Bioanalytik-muenster e.V (Germany), Nanobiotix SA (France), the Fondazione Don Carlo Gnocchi ONLUS (Italy), and SINTEF (Norway).

Contact
Mr. Nicolas Gouze
Head of ETP Nanomedicine Secretariat / NANOMED2020 coordinator
c/o VDI/VDE Innovation + Technik GmbH
nicolas.gouze@vdivde-it.de
http://www.etp-nanomedicine.eu

Wiebke Ehret | idw
Further information:
http://www.etp-nanomedicine.eu
http://www.etp-nanomedicine.eu/etpn-white-paper-2013

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>